Effect of angiotensin-converting enzyme inhibitors on progression of nondiabetic renal disease.
Publication
, Journal Article
Jafar, TH; Schmid, CH; Levey, AS
Published in: Annals of internal medicine
August 2002
Duke Scholars
Published In
Annals of internal medicine
DOI
EISSN
1539-3704
ISSN
0003-4819
Publication Date
August 2002
Volume
137
Issue
4
Start / End Page
298 / 299
Related Subject Headings
- Meta-Analysis as Topic
- Kidney Diseases
- Humans
- General & Internal Medicine
- Disease Progression
- Controlled Clinical Trials as Topic
- Angiotensin-Converting Enzyme Inhibitors
- 3202 Clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Jafar, T. H., Schmid, C. H., & Levey, A. S. (2002). Effect of angiotensin-converting enzyme inhibitors on progression of nondiabetic renal disease. Annals of Internal Medicine, 137(4), 298–299. https://doi.org/10.7326/0003-4819-137-4-200208200-00026
Jafar, Tazeen H., Christopher H. Schmid, and Andrew S. Levey. “Effect of angiotensin-converting enzyme inhibitors on progression of nondiabetic renal disease.” Annals of Internal Medicine 137, no. 4 (August 2002): 298–99. https://doi.org/10.7326/0003-4819-137-4-200208200-00026.
Jafar TH, Schmid CH, Levey AS. Effect of angiotensin-converting enzyme inhibitors on progression of nondiabetic renal disease. Annals of internal medicine. 2002 Aug;137(4):298–9.
Jafar, Tazeen H., et al. “Effect of angiotensin-converting enzyme inhibitors on progression of nondiabetic renal disease.” Annals of Internal Medicine, vol. 137, no. 4, Aug. 2002, pp. 298–99. Epmc, doi:10.7326/0003-4819-137-4-200208200-00026.
Jafar TH, Schmid CH, Levey AS. Effect of angiotensin-converting enzyme inhibitors on progression of nondiabetic renal disease. Annals of internal medicine. 2002 Aug;137(4):298–299.
Published In
Annals of internal medicine
DOI
EISSN
1539-3704
ISSN
0003-4819
Publication Date
August 2002
Volume
137
Issue
4
Start / End Page
298 / 299
Related Subject Headings
- Meta-Analysis as Topic
- Kidney Diseases
- Humans
- General & Internal Medicine
- Disease Progression
- Controlled Clinical Trials as Topic
- Angiotensin-Converting Enzyme Inhibitors
- 3202 Clinical sciences
- 11 Medical and Health Sciences